Selenium Or Compound Thereof Patents (Class 424/702)
-
Patent number: 8231910Abstract: A method of preparing a trace element solution includes the steps of providing at least one EDTA-complex, providing a sodium selenite solution, and combining the EDTA-complex(es) and the sodium selenite solution to form a trace element solution. An EDTA complex is prepared by using disodium EDTA or EDTA acid, selenium, and any other suitable mineral.Type: GrantFiled: October 28, 2003Date of Patent: July 31, 2012Assignee: Warburton Trading LimitedInventors: Robert Naylor Laurie, Lambertus Petrus Vosloo
-
Publication number: 20120189715Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.Type: ApplicationFiled: January 11, 2012Publication date: July 26, 2012Applicant: ABBOTT LABORATORIESInventors: Jeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
-
Publication number: 20120189717Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and subtantially lacking in free amino acids.Type: ApplicationFiled: January 11, 2012Publication date: July 26, 2012Applicant: ABBOTT LABORATORIESInventors: Jeffrey H. Baxter, Anne C. Voss, Pradip Mukerji, Michael J. Tisdale
-
Publication number: 20120189714Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.Type: ApplicationFiled: January 11, 2012Publication date: July 26, 2012Applicant: ABBOTT LABORATORIESInventors: Jeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
-
Publication number: 20120189716Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.Type: ApplicationFiled: January 11, 2012Publication date: July 26, 2012Applicant: ABBOTT LABORATORIESInventors: Jeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
-
Patent number: 8221799Abstract: The invention is directed to a method for administering antioxidant micronutrient formulations comprising multiple dietary and endogenous antioxidants, B-vitamins, vitamin D and minerals at appropriate dosages and dose schedules particularly chosen to produce long-term ‘optimal health’ effects in individuals of various age groups and occupations, with particular emphasis on reducing and/or eliminating acute and/or long term effects of environmental and physical stressors and toxic chemicals to which current Operating Forces and veterans of military service are or have been exposed.Type: GrantFiled: February 5, 2007Date of Patent: July 17, 2012Assignee: Premier Micronutrient CorporationInventors: Kedar N. Prasad, Gerald M. Haase, William C. Cole
-
Publication number: 20120177752Abstract: The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ?-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.Type: ApplicationFiled: January 11, 2012Publication date: July 12, 2012Applicant: ABBOTT LABORATORIESInventors: Jeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
-
Publication number: 20120171130Abstract: A composition is able to treat plant and animal diseases and includes a therapeutically effective amount of an encapsulated ionic mineral complex and a pharmaceutically acceptable carrier. The composition may also include other inert ingredients, botanical extracts and vitamin and mineral supplements.Type: ApplicationFiled: October 31, 2007Publication date: July 5, 2012Inventor: John Wayne Kennedy
-
Publication number: 20120164087Abstract: Dermatological compositions and method for treating psoriasis, eczema, acne and like skin conditions for sanitization pharmaceutical compounding and protection of the skin from extreme environmental conditions are provided which contain serum albumin in an amount effective to treat, reduce the symptoms and improve the appearance of affected skin due to psoriasis, eczema, and acne and like conditions, enhance the delivery performance or stability of pharmaceutical compounding bases, protect the skin from the environment and premature aging, and to lubricate and/or promote the healing of eye after surgical or accidental trauma, when combined with a suitable topical ointment, antibacterial or dermatological agent, pharmaceutical compounding ointment or bases, vehicle, carrier or excipient. The albumin compositions may be in any suitable form for treating skin, such as a cream, oil, lotion, gel, gel-based ointment, and the like.Type: ApplicationFiled: April 26, 2010Publication date: June 28, 2012Inventor: Daniel C. Carter
-
Patent number: 8202546Abstract: In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 300 mg of vitamin C; about 1200 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folate; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 300 mcg of biotin; about 50 mg of calcium; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 25 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 2 mg of lutein; about 500 mcg of lycopene; about 5 mg of pepper extract; and at least one or more excipients.Type: GrantFiled: February 2, 2010Date of Patent: June 19, 2012Assignee: Vertical Pharmaceuticals, Inc.Inventors: Steven A. Squashic, Kevin M. Hudy, David C. Purdy
-
Publication number: 20120148683Abstract: It pertains to a composition which comprises a combination of Aronia extract in an amount of at least about 10 ?g/mg and seleniumin in an amount from about 0.0001 ?g/mg to about 2.0 ?g/mg. The composition may further comprise zinc as additional micronutrient. The composition may be formulated as a pharmaceutical or a nutraceutical composition.Type: ApplicationFiled: May 6, 2010Publication date: June 14, 2012Applicant: URSAPHARM ARZNEIMITTEL GMBHInventors: Klaus Eschmann, Josef Beuth
-
Patent number: 8197854Abstract: A nutritional supplement for use in physiologically stressful conditions is disclosed. The nutritional supplement may include one or more of vitamin A, vitamin E, vitamin D3, vitamin C, vitamin B1, riboflavin, niacin, folic acid, vitamin B6, biotin, pantothenic acid, vitamin B12, magnesium, zinc, selenium, chromium, copper, iron, alpha lipoic acid, lutein and lycopene.Type: GrantFiled: March 7, 2011Date of Patent: June 12, 2012Assignee: Vertical Pharmaceuticals, Inc.Inventors: Steven A. Squashic, Kevin M Hudy, David C. Purdy
-
Publication number: 20120141594Abstract: A composition for treating damaged tissue and promoting healthy tissue growth, healing and tissue regeneration, wherein said composition comprises an extracellular matrix compound, a surface-active lipid, one or more enantiomerically pure L-amino acids or glycine, a hydrophilic surfactant with a high HLB, as well as vitamins, minerals or trace elements. Not only does it maintain good health, but the components are non-intrusive, bio-safe, non-coalescent and can mimic normally occurring stem-cells within a body. When applied to diseased tissues, the subject compositions can stimulate, facilitate, and accelerate protein synthesis for the regeneration of diseased organs and tissues. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system.Type: ApplicationFiled: February 8, 2012Publication date: June 7, 2012Applicant: IMMUNOPATH PROFILE, INC.Inventor: Leonard S. Girsh
-
Publication number: 20120141608Abstract: The invention is for the combination and related methods of N-acetyl-cysteine oral, inhaled, or intravenous, or glutathione inhaled or intravenous, generally in combination with antibiotic and/or antiviral therapy to ameliorate the toxic effects of infection with materials used in Bioterror incidents such as Bacillus anthracis and smallpox virus, and alternatively, upon exposure to radiation, during testing, and vaccination, as treatment prior to treatment with antibiotic or antiviral therapy to ameliorate the toxic effects of infection and exposure with these organisms.Type: ApplicationFiled: June 18, 2009Publication date: June 7, 2012Inventors: F. Timothy GUILFORD, Brooke SCHUMM, III
-
Publication number: 20120141601Abstract: Disclosed are a composition comprising chia seeds and maca, a dietary supplement or food additive, a feed and a pharmaceutical composition, all being based on the composition, and a method for preparing the dietary supplement, feed or pharmaceutical composition. The dietary supplement or food additive, the feed or feed additive, and the pharmaceutical composition exhibit can bring about excellent improvement in weight loss, sexual, gastrointestinal or hepatic function, male sex hormone release and endurance.Type: ApplicationFiled: August 11, 2010Publication date: June 7, 2012Applicant: Hanyang Patent FirmInventors: Younjin Kim, Hojun Kim
-
Publication number: 20120135091Abstract: The present invention concerns the use of active compounds, including chalcogenides and sirtuin-modulating compounds, either alone or in combination for increasing or enhancing survivability and/or longevity in biological matter. In general aspects, the chalcogenides and other active compounds may modulate one or more sirtuin proteins. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.Type: ApplicationFiled: January 18, 2008Publication date: May 31, 2012Inventors: Mark B. Roth, Dana L. Miller
-
Publication number: 20120114722Abstract: A method of preparing antimicrobial-containing polymeric products is provided, the method involving electrospinning a dispersion comprising a dispersible polymer, a fiberizing polymer, and one or more antimicrobial agents. The electrospun material is heated to remove solvent and the fiberizing polymer, giving a nonwoven polymeric material having antimicrobial agent incorporated therein. The material can be in the form of, for example, a non-woven sheet, tube, or covering.Type: ApplicationFiled: October 13, 2011Publication date: May 10, 2012Inventors: Robert L. Ballard, Bruce L. Anneaux, Joshua L. Manasco
-
Publication number: 20120114625Abstract: Shelf-stable fermented dairy products and methods of making the shelf-stable fermented dairy products are provided. The shelf-stable fermented dairy products can be shelf-stable with improved taste, viscosity and texture profiles. In a general embodiment, the present disclosure provides a shelf-stable fermented dairy product including a shelf-stable fermented dairy component, a stabilizer, and a puree composition. The shelf-stable fermented dairy component can be, for example, yogurt, sour cream, buttermilk or a combination thereof.Type: ApplicationFiled: April 23, 2010Publication date: May 10, 2012Inventors: Ana Lucia Wiessel, Allen Bruce Zerlaut, Frank Karl Welch
-
Publication number: 20120114743Abstract: Transdermal compositions containing castor oil are described. The compositions comprise ricinoleic acid and a transdermal vehicle with optional additional agents. One optional additional agent is an adrenergic drug which may cause the ricinoleic acid to penetrate the skin more deeply and have a longer lasting effect. The compositions can be used for treating a variety of ailments traditionally treated with castor oil or castor oil packs, without the mess and inconvenience of using castor oil packs.Type: ApplicationFiled: January 17, 2012Publication date: May 10, 2012Inventor: Keith Delprete
-
Publication number: 20120107410Abstract: The present invention relates to a product obtained from gastropod spawn, to be used to prepare dermatological, cosmetic or cosmeceutical compositions designed for skin care; said product has the capacity to activate and mobilise skin stem cells, as well as prevent the loss thereof that takes place as a consequence of chronological and premature ageing. The present invention also relates to the process followed in order to obtain said product.Type: ApplicationFiled: January 28, 2010Publication date: May 3, 2012Applicant: Industrial Farmaceutica Cantabria, S.A.Inventors: Marta Dominguez Valdes-Hevia, Aurora Brieva Delgado, Salvador Gonzalez Rodriguez, Eduardo Reyes Martin, Jose Carballeira Morado, Ernesto Quintana Gonzalez, Juan Pablo Pivel Ranieri, Antonio Guerrero Gomez-Pamo, Angeles Juarranz De La Fuente, Jesus Espada Regalado, Francisco Sanz Rodriguez
-
Publication number: 20120100223Abstract: Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area.Type: ApplicationFiled: December 20, 2011Publication date: April 26, 2012Applicant: ASHA NUTRITION SCIENCES, INC.Inventor: Urvashi BHAGAT
-
Publication number: 20120087877Abstract: The invention relates to a composition based on mineral concentrates and a method of preparing this composition. The composition comprises a powder or a mixture of powders containing at least one silicon derivative and at least one trace element other than silicon, as a mixture with a carrier and physiologically acceptable excipients. Application in cosmetology and dermatology for protecting the skin.Type: ApplicationFiled: October 14, 2011Publication date: April 12, 2012Applicant: BULGARI PARFUMSInventors: Jean-Claude ALLART, Jean-Marie Lefevre, Jacques Peyrot, Jean-Paul Marty
-
Publication number: 20120087994Abstract: The invention is for the combination and related methods of N-acetyl-cysteine oral, inhaled, or intravenous, or glutathione inhaled or intravenous, generally in combination with antibiotic and/or antiviral therapy to ameliorate the toxic effects of infection with materials used in Bioterror incidents such as Bacillus anthracis and smallpox virus, and alternatively, upon exposure to radiation, during testing, and vaccination, as treatment prior to treatment with antibiotic or antiviral therapy to ameliorate the toxic effects of infection and exposure with these organisms.Type: ApplicationFiled: December 19, 2011Publication date: April 12, 2012Inventors: F. Timothy Guilford, Brooke Schumm, III
-
Publication number: 20120076872Abstract: Modified green tea polyphenols and methods of their use are provided. One aspect provides compounds and compositions containing green tea polyphenols with one on more ester-linked fatty acids.Type: ApplicationFiled: November 28, 2011Publication date: March 29, 2012Inventor: Stephen D. Hsu
-
Patent number: 8142800Abstract: A practical high potency anti-craving oral medication or combined oral/IV drip medication is disclosed which comprises three components: a group of amino-acid substances, a group of vitamin substances, and a group of minerals, wherein each substance is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. The ingredients of the invention are selected to cooperate in easing metabolization in the bodies of individuals suffering the various medical conditions associated with substance abuse. The ingredients are provided orally to ease administration and to provide convenient use by patients: the oral medication may be a maintenance dosage or a corrective dosage.Type: GrantFiled: September 14, 2006Date of Patent: March 27, 2012Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore Keller
-
Patent number: 8142799Abstract: A practical high potency anti-craving medication is disclosed which comprises three components: an amino-acid component, a vitamin component, and a mineral component, wherein each component is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. Additionally, the active agents are received by means of a prolonged administration, preferably by means of an IV drip, thus assuring a period of time in which the active agents are present in desired concentrations, and more preferably a prolonged time during which they are simultaneously present in desired concentrations. The agents of each component are also selected so as to allow easy administration of the medication to patients in three vials of medication rather than as a large number of individual vials.Type: GrantFiled: August 20, 2005Date of Patent: March 27, 2012Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore R Keller
-
Publication number: 20120070422Abstract: A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically macular pigments, to prevent, treat, or delay the onset of age-related macular degeneration (AMD).Type: ApplicationFiled: September 21, 2011Publication date: March 22, 2012Applicant: KEMIN INDUSTRIES, INC.Inventor: Richard Roberts
-
Publication number: 20120040024Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.Type: ApplicationFiled: July 29, 2011Publication date: February 16, 2012Inventors: Mark B. Roth, Mike Morrison, Eric Blackstone, Dana Miller
-
Publication number: 20120039796Abstract: A bio compatible free radical suspension, comprising of oxygen and electronically modified reaction intermediates, where a fluorocarbon is used as an inert medium for stabilization of reaction intermediates. A stabilized bio compatible electronically modified derivative suspension is produced by the subjecting a fluorocarbon to certain stressors, such as oxidizing agents, reactive intermediates, physiological gases, benzo-?-pyrone derivatives, ultrasonic-cavitation, electric fields, magnetic fields, UV radiation, active metal catalyst, surfactant reactants, buffers, electrolytes, glucose, glucose derivatives, for the purpose of inducing a cascading immune response.Type: ApplicationFiled: August 13, 2011Publication date: February 16, 2012Inventor: Demetrios Markou
-
Publication number: 20120021073Abstract: The invention is for the combination and related methods of N-acetyl-cysteine oral, inhaled, or intravenous, or glutathione inhaled or intravenous, generally in combination with antibiotic and/or antiviral therapy to ameliorate the toxic effects of infection with materials used in Bioterror incidents such as Bacillus anthracis and smallpox virus, and alternatively, upon exposure to radiation, during testing, and vaccination, as treatment prior to treatment with antibiotic or antiviral therapy to ameliorate the toxic effects of infection and exposure with these organisms.Type: ApplicationFiled: June 18, 2009Publication date: January 26, 2012Inventors: F. Timothy GUILFORD, Brooke SCHUMM, III
-
Patent number: 8097281Abstract: The present invention relates to dosage forms for oral administration of therapeutic formulations, adapted to provide immediate and/or sustained-release of therapeutic substances, particularly for oral administration of vitamins. There is provided a dosage form for oral administration of a vitamin, comprising: a liquid phase containing a vitamin, e.g. Vitamin C in a relatively fast release form and a solid phase suspended in the liquid phase and containing a vitamin e.g. Vitamin C in a relatively slow release form.Type: GrantFiled: April 6, 2006Date of Patent: January 17, 2012Assignee: GlaxoSmithKline Consumer Healthcare GmbH & Co KGInventors: Stefan Heim, Martina Birgit Schmid, Christoph Walter Theurer
-
Publication number: 20120003316Abstract: This invention relates to a multi-configured, transmucosal pharmaceutical dosage form and, more particularly, to a pharmaceutical dosage form which has a single monolithic/heterogeneous layer or a plurality of such layers. The dosage form is suitable for the delivery of one or more pharmaceutical compositions via the buccal, sublingual, rectal, vaginal or transmucosal delivery route in a human or animal body. It provides for selected delivery profiles resulting from, but not limited to, a porosity-enabled composite matrix of one or more layers/components of the pharmaceutical composition/s. The invention also provides for a method of manufacturing said transmucosal pharmaceutical dosage form in a plurality of configurations.Type: ApplicationFiled: June 3, 2009Publication date: January 5, 2012Inventors: Deshika Reddy, Oluwatoyin Ayotomilola Adeleke, Viness Pillay, Yahya Choonara
-
Publication number: 20110311604Abstract: The invention relates to a domestic appliance, such as an iron, provided with a surface layer. The surface layer comprises an antimicrobial agent associated with a carrier, the carrier being inorganic and selected such that the antimicrobial activity of the surface layer according to JIS Z2801:2000 has a value of at least 2 after 100 hours of continuous use at a temperature of at least 230° C. In a preferred embodiment, the carrier is selected from the group consisting of a phosphate and a soluble silicate, while the antimicrobial agent is preferably selected from a group comprising ions of silver, zinc, copper, selenium, platinum or a combination thereof. The appliance stays fresher for a longer period of time than known hitherto. The invention further relates to an iron, a steam ironing device and a method of manufacturing the appliance.Type: ApplicationFiled: March 10, 2010Publication date: December 22, 2011Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.Inventors: Lingge Xu, Maarten Van Den Boogaard, Ya Ling Lee
-
Publication number: 20110305778Abstract: The present invention is directed to a stabilized anti-dandruff composition comprising about 10 wt. % to about 40 wt. % of an insoluble anti-dandruff agent, about 6 wt. % to about 12 wt. % of a stabilizer, less than about 1 wt. % of a preservative, and about 0.5 wt. % to about 1 wt. % of a neutralizer, and water. In an embodiment of the present invention, it is directed to a stabilized anti-dandruff composition comprising about 10 wt. % to about 25 wt. % of a zinc-containing layered material, about 6 wt. % to about 12 wt. % of a stabilizer, less than about 1 wt. % of a preservative, and about 0.5 wt. % to about 1 wt. % of a neutralizer, and water.Type: ApplicationFiled: June 9, 2011Publication date: December 15, 2011Inventors: Marco Caggioni, Douglas Allan Royce
-
Publication number: 20110305771Abstract: The present invention relates to a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport enhancement. The method comprises the administration of a therapeutically effective amount of krill and/or marine oil to a patient. The present invention also relates to a composition for the treatment and/or prevention of these diseases.Type: ApplicationFiled: August 24, 2011Publication date: December 15, 2011Applicant: Neptune Technologies & Bioressources Inc.Inventor: Tina Sampalis
-
Publication number: 20110293748Abstract: The present invention relates to a method of treating sepsis, systemic inflammatory response syndrome (SIRS), and/or septic shock in a patient. The method comprises administering (a) a pharmaceutical composition comprising a selenium-containing active substance, (b) a pharmaceutical composition comprising a corticoid-containing active substance, and (c) a pharmaceutical composition comprising insulin.Type: ApplicationFiled: August 11, 2011Publication date: December 1, 2011Applicant: Biosyn Arzneimittel GMBHInventor: Thomas STIEFEL
-
Publication number: 20110280851Abstract: Described herein are compositions that comprise cranberry extract and are potent and low in calories. Methods of preventing or treating infections by administering the described compositions are also provided.Type: ApplicationFiled: May 12, 2011Publication date: November 17, 2011Inventors: Alexander S. Herzlinger, Tina Shih-Ping Wu
-
Publication number: 20110268718Abstract: A method for producing a cactus fruit extract for use in formulating a beverage which can be used in the treatment of veisalgia.Type: ApplicationFiled: January 14, 2010Publication date: November 3, 2011Applicant: KAAHEE RESEARCH AND DEVELOPMENT GMBHInventor: Julian Rauchdobler
-
Publication number: 20110268683Abstract: A pourable ringing gel surfactant composition comprising a mixture of at least one anionic surfactant having a C8-C18 carbon chain and at least one zwitterionic or amphoteric surfactant having a C8-C18 carbon chain, wherein the ringing gel is capable of suspending solid or liquid particles without sedimentation.Type: ApplicationFiled: January 31, 2011Publication date: November 3, 2011Applicant: Rhodia, Inc.Inventors: John Hawkins, Pascal J. Herve, Ryan Murphy, Larry Hough
-
Publication number: 20110262564Abstract: Novel chemopreventive and chemotherapeutic cancer treatment method using elemental selenium nanoparticles. Cancer cells, especially androgen dependent prostate cancers are exposed to selenium from elemental selenium nanoparticle treatment, and apoptosis is induced in the cancer cells.Type: ApplicationFiled: June 18, 2010Publication date: October 27, 2011Inventors: Xueyun Gao, Ling Kong
-
Publication number: 20110262417Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.Type: ApplicationFiled: July 24, 2009Publication date: October 27, 2011Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.Inventors: Franco Gaetani, Ashraf Virmani
-
ANTIOXIDANT-CONTAINING FOOD COMPOSITION FOR USE IN ENHANCING ANTIVIRAL IMMUNITY IN COMPANION ANIMALS
Publication number: 20110256118Abstract: The invention encompasses methods for enhancing the ability of a companion animal to resist and/or overcome viral infections. The methods of the invention include an amount of lipoic acid that is effective in enhancing the antiviral immunity of a companion animal.Type: ApplicationFiled: December 16, 2009Publication date: October 20, 2011Applicant: Hill's Pet Nutrition, Inc.Inventors: Jeffrey A. Brockman, Nolan Zebulon Frantz, Steven C. Zicker -
Publication number: 20110250298Abstract: The present invention is a composition that can be taken by a user with an alcohol consuming lifestyle, to protect the user from liver damage as a result of consuming alcohol. The composition contains milk thistle extract, dandelion root, artichoke extract, vitamin E, selenium, thiamin, riboflavin, niacin, pyridoxine and cyanocobalamin. The alcohol is ethyl alcohol based drinks such as liquor, beer, wine or a combination of ethyl alcohol based drinks, liquor, beer or wine. The composition can be taken by a user in the form of a pill, a tablet or a capsule.Type: ApplicationFiled: April 13, 2010Publication date: October 13, 2011Inventor: Charles Muller
-
Patent number: 8029830Abstract: The present invention relates to a new composition comprising substances that promote DNA repair, reduce body fat levels and increase lean body mass and that decrease wrinkle appearance and/or improvement in skin surface. In some aspects, the composition of the present invention include resveratrol, forskohlin and astaxanthin. In another aspect the composition of the present invention further comprises carboxy alkyl ester. The present invention also relates to a method of promoting internal health and external appearance in a subject in need, said method comprising administering to the subject a composition that promotes DNA repair, reduces body fat levels and increases lean body mass and that decreases wrinkle appearance and/or improvement in skin surface.Type: GrantFiled: January 8, 2009Date of Patent: October 4, 2011Assignee: Nuvocare Health Services Inc.Inventor: Ryan Jason Foley
-
Publication number: 20110229538Abstract: Topical skin care compositions containing a combination of ascorbic acid or a derivative thereof, brown algae extract, and a blend of botanical extracts comprising cucumber extract, watercress extract, birch leaf extract, red clover extract, and St. John's wort extract, and, optionally, ginseng extract, as well as methods of using the same, are disclosed.Type: ApplicationFiled: March 17, 2011Publication date: September 22, 2011Applicant: ARBONNE INTERNATIONAL LLCInventors: Peter Matravers, Deborah Hicks, Sheree Wiener, Michele Arth
-
Publication number: 20110217277Abstract: The invention relates to a drug or a dermatological composition containing an avocado peptide extract for treating and/or preventing pruritus, in particular gravidic pruritus, pruritus sine materia, pruritus in newborns, and pruritus originating from a drug.Type: ApplicationFiled: November 6, 2009Publication date: September 8, 2011Inventors: Philippe Msika, Caroline Baudoin, Stéphanie Bredif
-
Patent number: 8003071Abstract: The invention relates to microbiological processes using non-selenium-respiring bacteria for the production of elemental selenium nanospheres having a size in the 50-500 nm range and compositions comprising said nanospheres. The invention further concerns grey elemental selenium nanospheres directly obtainable by the processes of the invention. The compositions and materials of the invention are useful, in particular, as food additives and for use as raw material in the microelectronic and optical industries.Type: GrantFiled: July 15, 2008Date of Patent: August 23, 2011Assignee: Dr. Aliment Kft.Inventors: József Prokisch, Mohsen A. Zommara
-
Publication number: 20110200556Abstract: Disclosed is a method for preventing the development of head and neck squamous cell carcinoma (HNSCC) in a mammal who is at risk for developing such carcinoma comprising administering an effective amount of a mammalian target of rapamycin (mTOR) inhibitor to the mammal. An example of such inhibitor is rapamycin.Type: ApplicationFiled: August 20, 2009Publication date: August 18, 2011Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH E SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIInventors: J. Silvio Gutkind, Panomwat Amornphimoltham, Vyomesh Patel, Alfredo Molinolo, Rakefet Czerninski
-
Patent number: 7993630Abstract: The present invention discloses certain heterocyclic complexes of metals of formula (I), especially those of manganese, which enhance the safety and efficacy of sunscreens via urocanate pathway modulation.Type: GrantFiled: July 4, 2009Date of Patent: August 9, 2011Assignee: Bioderm ResearchInventor: Shyam K Gupta
-
Patent number: RE42645Abstract: Nutritional or therapeutic compositions containing glutamic acid, cystine, glycine and a selenium precursor and methods for their utilization to increase glutathione synthesis and thereby enhance the immune system are described.Type: GrantFiled: March 9, 2006Date of Patent: August 23, 2011Inventor: Albert Crum